Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
G. Kim
Observed name:
Gang Kyu Kim
Institutions:
CHA University Bundang Medical Center,
CHA University
Observed institutions:
Yonsei University,
CHA University Bundang Medical Center,
CHA University,
Dankook University Hospital,
Yonsei University Mirae Campus
ORCID:
0009-0000-3954-3975
Observed ORCID:
0009-0000-3954-3975
OpenAlex ID:
A5040832075
Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea
2024
·
Gang Kyu Kim
, Young Heun Jo
, et al.
·
Korean journal of urology
·
6
PDF
1490P Infiltrative HCC defines a clinically and molecularly distinct subtype with poor clinical outcomes from atezolizumab plus bevacizumab
2025
·
H.J. Chon
, W.S. Lee
, et al.
·
Annals of Oncology
1493P Stratifying late progression risk beyond two years of immunotherapy using methylation-based ctDNA analysis in advanced HCC
2025
·
H.J. Chon
, H. Yang
, et al.
·
Annals of Oncology
193: Utility of Resistive Index in the Evaluation of Impaired Renal Function and Prognosis in Patients Resuscitated After Cardiac Arrest
2007
·
S. Oh
, M. Kim
, et al.
·
Annals of Emergency Medicine
Show more works
View as search
Works count:
4
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type